Next-Generation Alzheimer's Management: Early Identification, New Therapeutic Advances, and Patient-Centered Care

Next-Generation Alzheimer's Management: Early Identification, New Therapeutic Advances, and Patient-Centered Care is a bold step forward in equipping healthcare professionals to meet the urgent challenges of Alzheimer’s care. Developed by Iridium Continuing Education in collaboration with Global Education Group, this dynamic CME activity harnesses the power of adaptive learning to deliver short, high-impact modules grounded in real-world clinical decision-making.

Through immersive case-based scenarios, providers explore how to recognize early signs of Alzheimer’s, integrate biomarker testing into routine practice, and apply the latest evidence on disease-modifying therapies. The program also shines a light on care disparities—particularly in rural and underserved communities—and offers practical, team-based approaches to improve access, support caregivers, and personalize care.

By blending clinical rigor with innovative educational design, this initiative empowers clinicians to take immediate, meaningful steps toward earlier diagnosis and better outcomes for patients and families navigating Alzheimer’s disease.